Biomarkers – Products

This application note examines an advanced proteomics platform designed to provide high precision across thousands of proteins, enabling reliable results even in large-scale and longitudinal studies.

Thermo Fisher Scientific has received approval from the U.S. Food and Drug Administration (FDA) for its Ion Torrent™ Oncomine™ Dx Target Test as a companion diagnostic (CDx) to identify patients eligible for treatment with Servier Pharmaceuticals.

MOBILion Systems, Inc., announced a next-generation approach for complex sample analysis poised to disrupt the mass spectrometry industry as it delivers unparalleled speed, sensitivity, specificity and quantitative accuracy.

Diagnostic company SphingoTec GmbH (“SphingoTec”) announced a new partnership with Beckman Coulter Diagnostics Inc. (“Beckman Coulter”).

Owlstone Medical (“Owlstone”), announced it has entered into a Research Collaboration Agreement with the FDA’s Center for Devices and Radiological Health (“CDRH”) - Office of Science and Engineering Laboratories (OSEL).

Azenta, Inc. has announced its participation in the FinnGen project, a large-scale research initiative at the forefront of personalized medicine in Finland.

This application note provides insights into innovative methodologies designed to enhance miRNA discovery and mapping from low-input samples.

This whitepaper explores innovative proteomic tools that offer insights into protein signatures and that can serve as biomarkers for aging.

This app note highlights a multiplex immunofluorescence imaging solution for targeted spatial proteomics that provides several advantages over other spatial proteomic and transcriptomic technologies for biomarker studies.

Archer CGP research assays now enable homologous recombination deficiency (HRD) assessment for identification of key biomarkers critical for cancer research.